Project Number 3R01AG062624-02S1 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Metformin in Alzheimer's dementia Prevention (MAP) Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator LUCHSINGER, JOSE Principal Investigator First Name JOSE Principal Investigator Last Name LUCHSINGER Awardee Organization COLUMBIA UNIVERSITY Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-878: Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) FY Overall Cost $3,234,307 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
